dc.creatorWILDER-SMITH, Annelies
dc.creatorCHEN, Lin H.
dc.creatorMASSAD, Eduardo
dc.creatorWILSON, Mary E.
dc.date.accessioned2012-04-18T21:33:49Z
dc.date.accessioned2018-07-04T14:34:55Z
dc.date.available2012-04-18T21:33:49Z
dc.date.available2018-07-04T14:34:55Z
dc.date.created2012-04-18T21:33:49Z
dc.date.issued2009
dc.identifierEMERGING INFECTIOUS DISEASES, v.15, n.1, p.8-11, 2009
dc.identifier1080-6040
dc.identifierhttp://producao.usp.br/handle/BDPI/15167
dc.identifier10.3201/eid1501.071097
dc.identifierhttp://dx.doi.org/10.3201/eid1501.071097
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1612007
dc.description.abstractDengue, the most common arbovirus infection globally, is transmitted by mosquito vectors. Healthcare-related transmission, including transmission by blood products, has been documented, although the frequency of these occurrences is unknown. Dengue is endemic to Singapore, a city-state in Asia. Using mathematical modeling, we estimated the risk for dengue-infected blood transfusions in Singapore in 2005 to be 1.625-6/10,000 blood transfusions, assuming a ratio of asymptomatic to symptomatic infections of 2:1 to 10:1. However, the level of viremia required to cause clinical dengue cases is person-dependent and unknown. Further studies are needed to establish the magnitude of the threat that dengue poses to blood safety in countries where it is endemic. It will then be possible to assess whether screening is feasible and to identify approaches that are most cost-effective on the basis of characteristics of local populations and seasonality of dengue.
dc.languageeng
dc.publisherCENTERS DISEASE CONTROL
dc.relationEmerging Infectious Diseases
dc.rightsCopyright CENTERS DISEASE CONTROL
dc.rightsopenAccess
dc.titleThreat of Dengue to Blood Safety in Dengue-Endemic Countries
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución